Analysis of PTEN and the 10q23 region in primary prostate carcinomas.
- Published in:
- Oncogene, 1998, v. 16, n. 13, p. 1743, doi. 10.1038/sj.onc.1200205
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 1998 AND VI 16 AND IP 13
Results: 15
1
2
Hyperphosphorylated p107 and p130 bind to T-antigen: identification of a critical regulatory sequence present in RB but not in p107/p130.
- Published in:
- Oncogene, 1998, v. 16, n. 13, p. 1655, doi. 10.1038/sj.onc.1201682
- By:
- Publication type:
- Article
3
Association of PKC δ and active Src in PMA-treated MCF-7 human breast cancer cells.
- Published in:
- Oncogene, 1998, v. 16, n. 13, p. 1649, doi. 10.1038/sj.onc.1201684
- By:
- Publication type:
- Article
4
In B16 melanoma cells, the inhibition of melanogenesis by TPA results from PKC activation and diminution of microphthalmia binding to the M-box of the tyrosinase promoter.
- Published in:
- Oncogene, 1998, v. 16, n. 13, p. 1665, doi. 10.1038/sj.onc.1201685
- By:
- Publication type:
- Article
5
Activation loop tyrosines contribute varying roles to TrkB autophosphorylation and signal transduction.
- Published in:
- Oncogene, 1998, v. 16, n. 13, p. 1691, doi. 10.1038/sj.onc.1201688
- By:
- Publication type:
- Article
6
TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer.
- Published in:
- Oncogene, 1998, v. 16, n. 13, p. 1671, doi. 10.1038/sj.onc.1201690
- By:
- Publication type:
- Article
7
Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner.
- Published in:
- Oncogene, 1998, v. 16, n. 13, p. 1701, doi. 10.1038/sj.onc.1201691
- By:
- Publication type:
- Article
8
Activation of the Xmrk proto-oncogene of Xiphophorus by overexpression and mutational alterations.
- Published in:
- Oncogene, 1998, v. 16, n. 13, p. 1681, doi. 10.1038/sj.onc.1201693
- By:
- Publication type:
- Article
9
Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).
- Published in:
- Oncogene, 1998, v. 16, n. 13, p. 1731, doi. 10.1038/sj.onc.1201694
- By:
- Publication type:
- Article
10
An oncogenic fusion product of the phosphatidylinositol 3-kinase p85β subunit and HUMORF8, a putative deubiquitinating enzyme.
- Published in:
- Oncogene, 1998, v. 16, n. 13, p. 1767, doi. 10.1038/sj.onc.1201695
- By:
- Publication type:
- Article
11
Activation of protein kinase C δ by the c-Abl tyrosine kinase in response to ionizing radiation.
- Published in:
- Oncogene, 1998, v. 16, n. 13, p. 1643, doi. 10.1038/sj.onc.1201698
- By:
- Publication type:
- Article
12
Defining the minimal requirements for papilloma viral E6-mediated inhibition of human p53 activity in fission yeast.
- Published in:
- Oncogene, 1998, v. 16, n. 13, p. 1759, doi. 10.1038/sj.onc.1201848
- By:
- Publication type:
- Article
13
BRCA1 physically associates with p53 and stimulates its transcriptional activity.
- Published in:
- Oncogene, 1998, v. 16, n. 13, p. 1713, doi. 10.1038/sj.onc.1201932
- By:
- Publication type:
- Article
14
Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation.
- Published in:
- Oncogene, 1998, v. 16, n. 13, p. 1723, doi. 10.1038/sj.onc.1201933
- By:
- Publication type:
- Article
15
Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation.
- Published in:
- Oncogene, 1998, v. 16, n. 13, p. 1749, doi. 10.1038/sj.onc.1201972
- By:
- Publication type:
- Article